- Home
- RLAY vs TREE Comparison
RLAY vs TREE Comparison
Compare RLAY & TREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- TREE
- Stock Information
- Founded
- RLAY 2015
- TREE 1996
- Country
- RLAY United States
- TREE United States
- Employees
- RLAY N/A
- TREE N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- TREE Finance: Consumer Services
- Sector
- RLAY Health Care
- TREE Finance
- Exchange
- RLAY Nasdaq
- TREE Nasdaq
- Market Cap
- RLAY 490.3M
- TREE 549.4M
- IPO Year
- RLAY 2020
- TREE N/A
- Fundamental
- Price
- RLAY $3.18
- TREE $34.87
- Analyst Decision
- RLAY Strong Buy
- TREE Buy
- Analyst Count
- RLAY 11
- TREE 8
- Target Price
- RLAY $18.40
- TREE $64.13
- AVG Volume (30 Days)
- RLAY 1.5M
- TREE 276.3K
- Earning Date
- RLAY 08-05-2025
- TREE 07-24-2025
- Dividend Yield
- RLAY N/A
- TREE N/A
- EPS Growth
- RLAY N/A
- TREE N/A
- EPS
- RLAY N/A
- TREE N/A
- Revenue
- RLAY $7,679,000.00
- TREE $972,179,000.00
- Revenue This Year
- RLAY $14.31
- TREE $11.20
- Revenue Next Year
- RLAY N/A
- TREE $7.39
- P/E Ratio
- RLAY N/A
- TREE N/A
- Revenue Growth
- RLAY N/A
- TREE 51.96
- 52 Week Low
- RLAY $1.78
- TREE $33.50
- 52 Week High
- RLAY $10.72
- TREE $62.49
- Technical
- Relative Strength Index (RSI)
- RLAY 55.48
- TREE 42.03
- Support Level
- RLAY $2.98
- TREE $33.50
- Resistance Level
- RLAY $3.48
- TREE $35.62
- Average True Range (ATR)
- RLAY 0.25
- TREE 1.25
- MACD
- RLAY -0.00
- TREE 0.24
- Stochastic Oscillator
- RLAY 58.45
- TREE 33.09
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About TREE LendingTree Inc.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.